Published in Virology on February 01, 1992
Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. J Virol (1993) 1.27
Coevolution of persistently infecting small DNA viruses and their hosts linked to host-interactive regulatory domains. Proc Natl Acad Sci U S A (1993) 1.16
Natural biology of polyomavirus middle T antigen. Microbiol Mol Biol Rev (2001) 1.02
Enhancer dependence of polyomavirus persistence in mouse kidneys. J Virol (1992) 1.01
n-Butyrate, a cell cycle blocker, inhibits the replication of polyomaviruses and papillomaviruses but not that of adenoviruses and herpesviruses. J Virol (1994) 0.98
Aphidicolin-resistant polyomavirus and subgenomic cellular DNA synthesis occur early in the differentiation of cultured myoblasts to myotubes. J Virol (1993) 0.75
Hybridization in situ of SV40 plaques: detection of recombinant SV40 virus carrying specific sequences of nonviral DNA. Science (1977) 5.75
Determination of molar ratios of vesicular stomatitis virus induced RNA species in BHK21 cells. Biochemistry (1976) 2.69
Mutational alterations within the simian virus 40 leader segment generate altered 16S and 19S mRNA's. J Virol (1979) 2.61
Persistent noncytocidal vesicular stomatitis virus infections mediated by defective T particles that suppress virion transcriptase. Proc Natl Acad Sci U S A (1974) 2.34
Use of subgenomic poliovirus DNA hybridization probes to detect the major subgroups of enteroviruses. J Clin Microbiol (1984) 1.90
Synthesis of poly(A) in vitro by purified virions of vesicular stomatitis virus. Nat New Biol (1973) 1.83
The primary site of replication alters the eventual site of persistent infection by polyomavirus in mice. J Virol (1984) 1.73
Factors involved in the generation and replication of rhabdovirus defective T particles. J Virol (1976) 1.72
Long-term persistent vesicular stomatitis virus and rabies virus infection of cells in vitro. J Gen Virol (1976) 1.71
Purification of defective interfering T particles of vesicular stomatitis and rabies viruses generated in vivo in brains of newborn mice. Virology (1975) 1.54
Detection of DNA and RNA virus genomes in organ systems of whole mice: patterns of mouse organ infection by polyomavirus. J Virol (1984) 1.50
An SV40 deletion mutant accumulates late transcripts in a paranuclear extract. Virology (1982) 1.49
Factors affecting the detection of enteroviruses in cerebrospinal fluid with coxsackievirus B3 and poliovirus 1 cDNA probes. J Clin Microbiol (1985) 1.47
RNA polymerase activity and poly(A) synthesizing activity in defective T particles of vesicular stomatitis virus. Virology (1974) 1.41
Developmental expression of rat transforming growth factor-alpha mRNA. Mol Cell Biol (1985) 1.36
Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. J Virol (1993) 1.27
Direct transfection of viral and plasmid DNA into the liver or spleen of mice. Proc Natl Acad Sci U S A (1984) 1.22
Genetic analysis of the enhancer requirements for polyomavirus DNA replication in mice. J Virol (1990) 1.19
Simian virus 40-rabbit beta-globin recombinants lacking late mRNA splice sites express cytoplasmic RNAs with altered structures. J Virol (1982) 1.18
Coevolution of persistently infecting small DNA viruses and their hosts linked to host-interactive regulatory domains. Proc Natl Acad Sci U S A (1993) 1.16
A splice junction deletion deficient in the transport of RNA does not polyadenylate nuclear RNA. Mol Cell Biol (1983) 1.16
A pancreas specificity results from the combination of polyomavirus and Moloney murine leukemia virus enhancer. Proc Natl Acad Sci U S A (1987) 1.12
Parvovirus variation for disease: a difference with RNA viruses? Curr Top Microbiol Immunol (2006) 1.10
Functional analysis of the individual enhancer core sequences of polyomavirus: cell-specific uncoupling of DNA replication from transcription. Mol Cell Biol (1988) 1.08
Lymphoid and other tissue-specific phenotypes of polyomavirus enhancer recombinants: positive and negative combinational effects on enhancer specificity and activity. Mol Cell Biol (1986) 1.08
Natural biology of polyomavirus middle T antigen. Microbiol Mol Biol Rev (2001) 1.02
Enhancer dependence of polyomavirus persistence in mouse kidneys. J Virol (1992) 1.01
Transcribing complexes in cells infected by vesicular stomatitis virus and rabies virus. J Virol (1974) 1.00
n-Butyrate, a cell cycle blocker, inhibits the replication of polyomaviruses and papillomaviruses but not that of adenoviruses and herpesviruses. J Virol (1994) 0.98
Host species specificity of polyomavirus DNA replication is not altered by simian virus 40 72-base-pair repeats. Mol Cell Biol (1985) 0.98
A comparison of biochemical and biological properties of standard and defective lymphocytic choriomeningitis virus. Bull World Health Organ (1975) 0.95
Minimal subenhancer requirements for high-level polyomavirus DNA replication: a cell-specific synergy of PEA3 and PEA1 sites. Mol Cell Biol (1990) 0.93
Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model. Gynecol Oncol (2000) 0.93
The evolution of small DNA viruses of eukaryotes: past and present considerations. Virus Genes (1995) 0.90
Leakage of nuclear transcripts late in simian virus 40-infected CV1 cells: quantitation of spliced and unspliced late 19S RNAs. J Virol (1980) 0.90
Whole animal section in situ hybridization and protein blotting: new tools in molecular analysis of animal models for human disease. Curr Top Microbiol Immunol (1989) 0.88
Polyomavirus DNA replication in the pancreas and in a transformed pancreas cell line has distinct enhancer requirements. J Virol (1991) 0.86
Polyomavirus replicates in differentiating but not in proliferating tubules of adult mouse polycystic kidneys. Virology (1994) 0.85
RNA synthesis in BHK 21 cells persistently infected with vesicular stomatitis virus and rabies virus. J Gen Virol (1976) 0.84
Tissue specific phenotypes of polyomavirus A and B enhancer transpositions and duplications: positional and nonpositional effects on replication in lymphoid cells. Virus Genes (1987) 0.82
A small RNA complementary to an intervening sequence is produced late in SV40 infection. Nature (1981) 0.81
Potential role of DNA polymerase beta in gene therapy against cancer: a case for colorectal cancer. Med Hypotheses (1996) 0.80
A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice. Virology (1995) 0.79
The distribution and kinetics of polyomavirus in lungs of intranasally infected newborn mice. Virology (2000) 0.78
Approaches to study interactions between small DNA viruses and differentiated tissue. Methods (1998) 0.78
The secretory cells of mouse salivary glands are nonpermissive for polyomavirus replication. Virology (1994) 0.78
E1A represses wild-type and F9-selected polyomavirus DNA replication by a mechanism not requiring depression of large tumor antigen transcription. J Virol (1991) 0.77
Prediction of gene therapy-induced tumor size changes by the vascularity changes measured using dynamic contrast-enhanced MRI. Magn Reson Imaging (2000) 0.77
Parvovirus-mediated antineoplastic activity exploits genome instability. Med Hypotheses (2000) 0.76
Transduction of hippocampal CA1 by adenovirus in vivo. Brain Res (1996) 0.76
Replication dependent and cell specific activation of the polyomavirus early promoter. Nucleic Acids Res (1991) 0.76
Aphidicolin-resistant polyomavirus and subgenomic cellular DNA synthesis occur early in the differentiation of cultured myoblasts to myotubes. J Virol (1993) 0.75
Mapping of polyomavirus DNA replicative intermediates by two-dimensional gel analysis using chemiluminescent detection. J Virol Methods (1996) 0.75
Prevention of cervical cancer with vaccines. Curr Oncol Rep (2001) 0.75
Comparison of the transient late region expression of SV40 DNA and SV40-based shuttle vectors: development of a new shuttle vector that is efficiently expressed. J Mol Appl Genet (1985) 0.75
The use of oligonucleotide directed cleavage of DNA and homologous recombination in the production of large recombinant adenoviral vectors. Gene Ther (2000) 0.75
n-Butyrate mediated inhibition of papovavirus DNA replication in vivo and in cell culture: a mechanistic approach. Virus Genes (2000) 0.75
T-Ag inhibits implantation by EC cell derived embryoid bodies. Virus Genes (2000) 0.75